key: cord-0958273-4pb1ktpt authors: Gibbon, Lindsay M.; GrayBuck, Katherine E.; Buck, Laura I.; Huang, Kuang-Ning; Penumarthy, Neela L.; Wu, Shirou; Curtis, J. Randall title: Development and Implementation of a Clinician-facing Prognostic Communication Tool for Patients with COVID-19 and Critical Illness date: 2020-05-08 journal: J Pain Symptom Manage DOI: 10.1016/j.jpainsymman.2020.05.005 sha: 150cf9ab15ed41bc8266540eee211d2a0a145e45 doc_id: 958273 cord_uid: 4pb1ktpt Abstract Effective prognostication for a novel disease presents significant challenges, especially given the stress induced during a pandemic. We developed a point-of-care tool to summarize outcome data for critically ill patients with COVID-19 and help guide clinicians through a thoughtful prognostication process. Two authors reviewed studies of outcomes of patients with critical illness due to COVID-19 and created a visual infographic tool based on available data. Survival data were supplemented by descriptions of best and worst-case clinical scenarios. The tool also included prompts for clinician reflection designed to enhance awareness of cognitive biases that may affect prognostic accuracy. This online, open source COVID-19 Prognostication Tool has been made available to all clinicians at our institution and is updated weekly to reflect evolving data. Our COVID-19 Prognostication Tool may provide a useful approach to promoting consistent and high-quality prognostic communication across a healthcare system. Patients and families with serious illness rely upon healthcare teams to provide accurate information about prognosis. Skillfully delivered prognostic information prompts patients and families to imagine how their lived experience will change on each potential treatment path, thereby empowering them to fully participate in shared decision-making about the path that aligns best with the patient's values and goals. 1, 2 Unfortunately, clinicians face formidable challenges when attempting to deliver clear prognostic information to the families of critically ill patients with COVID- 19 . Existing data about survival rates are rapidly evolving and difficult to interpret with confidence because of variability in care settings and incomplete patient followup in most studies. [3] [4] [5] [6] [7] [8] [9] [10] The limited experience of any given clinician with long-term outcomes of patients with this novel disease inherently limits the value of experiential prognostication. Moreover, important data about quality-of-life outcomes will take months or years to develop due to the lengthy convalescent period for most critically ill patients with COVID-19. Given the limited data available about COVID-19 and the heightened emotional challenges of caring for patients in a pandemic, clinicians may be particularly vulnerable to cognitive biases during the process of prognostication. Early in our institution's experience with the COVID-19 pandemic, our palliative care consult team noticed several recurring themes of cognitive bias during interdisciplinary team discussions. Recognizing the importance of providing the most objective and consistent prognostic information possible to patients and families, we created a COVID-19 Prognostication Tool designed to accomplish four objectives. First, the tool collates the latest peer-reviewed prognostic information about critically ill patients with COVID-19 into a concise, easily accessible, up-to-date prognostication guide. Second, the tool guides clinicians through a careful process to mitigate the effects of cognitive biases on their ability to communicate about prognosis with patients and families. Third, the tool prompts clinicians to translate population-based statistical information into best-case, worst-case and most likely scenarios for a given patient. 2 Fourth, the tool encourages providers to seek information about patient values that can inform clinician recommendations for medically-appropriate, value-concordant care. This report describes the development and implementation of a point-of-care COVID-19 Prognostic Tool to guide best practices of relaying prognostic information to the families of critically ill patients with COVID-19 and makes this tool available to others for adaptation and implementation. We identified three cognitive biases 11,12 that we observed impacting clinical team discussions of prognosis for critically ill patients with COVID-19 at our institution: anchoring bias, availability bias, and false consensus bias. The Prognostication Tool was designed to explicitly address these three biases described here. Anchoring bias: 12 Early in the pandemic, "Crisis Standards of Care" was a frequent topic of discussion as our institution prepared for a predicted surge of patients with COVID-19. Clinicians contemplated the frightening possibility of reaching a crisis state where resource scarcity would prevent us from offering advanced life support to chronically ill, elderly patients with the poorest prognoses. The impact of these emotionally-charged discussions was significant. Even when staffing, ventilators, and other resources remained at objectively adequate levels, providers often continued to subconsciously anchor on a "Crisis Standards of Care" mindset, proposing limits on aggressive treatment modalities due to concerns about future resource scarcity rather than actual scarcity or patient values. Availability bias: 12 Clinicians who have recently cared for a dying patient with COVID-19 can grow more pessimistic about outcomes for all critically ill patients with COVID-19, and may be more likely to overestimate subsequent individual patients' mortality risk. At times, a feeling of therapeutic nihilism seemed predominant on our healthcare teams, prompting moral distress among physicians, nurses, and others. Some family members also perceived disproportionate provider pessimism and warned against the perpetuation of self-fulfilling prophecies. False consensus bias: [13] [14] [15] Our COVID-19 Prognostication Tool was developed as a point-of-care guide to help front-line clinicians respond to the cognitive challenges of prognosticating during an evolving pandemic. The tool is a concise, open source document that can be viewed online. 16 The current tool at the time of publication is captured in this article, but the open source tool will be updated as new data emerge. prognosticate for an individual patient. First, the framework directs providers to imagine bestcase, worst-case and most likely scenarios for the individual patient. Second, clinicians are asked to consider whether each treatment option is likely to "work" for the patient on a physiologic level. These two steps attempt to enhance provider awareness of inappropriate therapeutic nihilism by prompting providers to go through the cognitive step of considering the likelihood of benefit from each treatment option. Third, the framework attempts to challenge false consensus bias by explicitly directing the provider to ask for the patient and family's perspective on minimum acceptable quality of life, rather than relying on assumptions that may have been made by the clinical team. The point-of-care COVID-19 Prognostication Tool has been disseminated to front-line clinicians at our institution, as well as a local community hospital, and will be updated weekly to reflect newly published outcome data. Clinicians at our institution are invited to use the tool as a source of information about major prognostic trajectories for this novel disease, as well as a reminder of the need to continuously re-calibrate our clinical impressions as new peerreviewed evidence emerges. Qualitative feedback on the tool has been positive, but we were not able to conduct a rigorous evaluation in the context of our pandemic response. Our COVID-19 Prognostication Tool has several important limitations. First, the visual summary of patient outcomes is based on limited data from early studies and is likely to change as the pandemic evolves. Moreover, patient outcome data vary widely across studies due to length of study follow-up and regional differences in resource availability, treatment protocols, and approaches to withdrawal of life-sustaining treatment. Our team strives to update our visual summary of patient outcomes at least weekly with a concerted effort to capture pervasive, big-picture trends in survival. However, our interpretation of the data inevitably involves some degree of subjectivity. Second, this prognostication tool can only be useful when it is thoughtfully applied to the patient population and clinical circumstances for which it is intended: critically ill patients with COVID-19. Third, up-to-date and accurate prognostic information is only one step in effective prognostic communication with patients and family members. Supportive and effective communication of prognostic information is an important skill with multiple components, many of which are not addressed by this tool. 1, 19, 20 Fourth, our prognostication tool focuses on three cognitive biases that we observed at our institution but may not be universally applicable to all centers; reflection prompts may need to be adapted depending on the cognitive biases that are prevalent within each institutional culture. Finally, our evaluation of this tool is subjective and preliminary. Our goal was to share the tool quickly for others to adapt, implement, and evaluate in the context of this novel pandemic. Additional evaluation will be important to understand and improve the effectiveness of the tool. We have developed and implemented a point-of-care prognostic communication tool for clinicians caring for critically ill patients with COVID-19. Although this tool will need to be updated as additional evidence emerges, we present the tool and its development as a model of one approach to promote consistent and high-quality prognostic communication across a healthcare system. Our hope is that the tool will help clinicians develop an approach to communication about prognosis that is practical and patient-and family-centered. The best- Practical Guidance for Evidence-Based ICU Family Conferences Best Case/Worst Case": Training surgeons to use a novel communication tool for high-risk acute surgical problems Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State Covid-19 in Critically Ill Patients in the Seattle Region -Case Series SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area From mindless to mindful practice--cognitive bias and clinical decision making Judgment under Uncertainty: Heuristics and Biases false consensus effect": An egocentric bias in social perception and attribution processes Seeing me, seeing you: Testing competing accounts of assumed similarity in personality judgments Projection in surrogate decisions about life-sustaining medical treatments COVID-19 Prognostication Tool A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus Accessed May 3, 2020. www.vitaltalk.org COVID-19 data evolves daily. Last updated 4/23/20. The survival rates above are ballpark estimates. Outcomes may vary depending on institutional practices and resource availability COVID-19 data evolves daily. Last updated 4/23/20. The survival rates above are ballpark estimates. Outcomes may vary depending on institutional practices and resource availability. Use your clinical judgement and the strategies on the next slide to determine how the survival estimates above apply to each patient under your care. generally >70 years and/or multi-organ involvement